Table 3.
Subtype | Breast cancer-specific mortality | ||||||||
---|---|---|---|---|---|---|---|---|---|
Overall | Pre-menopausal | Post-menopausal | |||||||
Total | Deaths | HR | Total | Deaths | HR | Total | Deaths | HR | |
Luminal-A | 90 | 2 | 42 | 1 | 48 | 1 | |||
<24 | 35 | 0 | 1 | 19 | 0 | 1 | 16 | 0 | 1 |
≥24 | 55 | 2 | 53.033 | 23 | 1 | 105.823 | 32 | 1 | 38.408 |
P | P = 0.512 | P = 0.095 | P = 0.376 | ||||||
Luminal-B(HER2−) | 591 | 58 | 282 | 8 | 309 | 20 | |||
<24 | 236 | 21 | 1 | 139 | 3 | 1 | 97 | 18 | 1 |
≥24 | 355 | 37 | 1.579 | 143 | 5 | 5.170 | 212 | 32 | 1.221 |
P | P = 0.049 | P = 0.075 | P = 0.661 | ||||||
Luminal-B(HER2+) | 116 | 12 | 74 | 10 | 42 | 2 | |||
<24 | 55 | 3 | 1 | 39 | 3 | 1 | 26 | 0 | 1 |
≥24 | 61 | 9 | 1.653 | 35 | 7 | 0.850 | 16 | 2 | 42.807 |
P | P = 0.491 | P = 0.862 | P = 0.551 | ||||||
HER2 overexpression | 239 | 36 | 124 | 28 | 115 | 8 | |||
<24 | 101 | 9 | 1 | 55 | 5 | 1 | 46 | 4 | 1 |
≥24 | 138 | 27 | 2.966 | 69 | 23 | 4.305 | 69 | 4 | 1.196 |
P | P = 0.007 | P = 0.004 | P = 0.985 | ||||||
Triple negative | 189 | 63 | 118 | 58 | 71 | 5 | |||
<24 | 79 | 24 | 1 | 48 | 22 | 1 | 31 | 2 | 1 |
≥24 | 110 | 39 | 2.035 | 70 | 36 | 1.775 | 40 | 3 | 2.151 |
P | P = 0.018 | P = 0.048 | P = 0.372 |
Abbreviations: BCSS, breast cancer-specific survival; HR, hazard ratio.